Literature Archives

Flexible bronchoscopy is safe for elderly patients, with procedural complexity—not age—being the primary driver of risk

A validated, multicenter nomogram integrating the pleural fluid ADA-to-LDH ratio offers a superior, user-friendly tool for distinguishing tuberculous from malignant pleural effusions. This predictive model enhances diagnostic accuracy by improving upon individual biomarker performance.

Essential reading for IP practitioners to understand and mitigate risks associated with EBUS-TBNA and cryobiopsy.

While BAL cellular profiles are a vital supportive tool—especially for identifying lymphocytosis in non-fibrotic lung diseases—they lack the standalone specificity to definitively diagnose fibrotic ILDs and must be integrated into a multidisciplinary discussion.

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) provides a viable, minimally invasive source of high-quality tissue for generating patient-derived lung cancer models, effectively bridging the gap between diagnostic sampling and precision oncology.

First-line indwelling pleural catheter (IPC) insertion efficiently manages all malignant pleural effusions, allowing for subsequent talc pleurodesis in suitable patients while avoiding the need for pre-assessment of lung expansion. A real-world study showed that this approach achieves high success rates for both immediate talc therapy and long-term symptom-guided drainage.

EBUS-guided transbronchial mediastinal cryobiopsy (EBUS-TBMC) provides superior diagnostic yield for MHL compared to traditional needle aspiration (EBUS-TBNA), particularly for benign conditions and lymphoma, while maintaining an acceptable safety profile

Bronchoscopy remains the gold standard for the diagnosis and management of airway casts in pediatric plastic bronchitis.

Highlights the need for improved communication strategies when delivering potentially malignant bronchoscopy findings to patients.

Provides essential procedural guidance for expanding cryotherapy applications into the pediatric population.

EBUS-TBNA is a highly effective, minimally invasive tool for staging non-pulmonary cancers involving the mediastinum.

Slim EBUS with navigation bronchoscopy improves diagnostic access to challenging, distal peripheral lesions that standard, larger equipment cannot reach.